NewcelX NCEL
NASDAQ NCEL
$2.80 +0.04 (+1.37%)
As of: Oct 21, 2026 · 9:44 AM EDT

NewcelX (NCEL) Common Equity (2019 - 2026)

Updated

NewcelX's Common Equity was $6.04 million in Q2 2026, compared with -$15.8 million a year earlier.

Analysis

NewcelX (NCEL) Common Equity (2019 - 2026) Analysis & Trends

At the end of FY2025, Common Equity at NewcelX came in at $7.25 million.

  • In earlier years, Common Equity was -$8 million in FY2024, -$1.2 million in FY2023, $111,000 in FY2022 (-79.5%) and $542,388 in FY2021.
  • Quarterly Common Equity has moved between -$15.8 million (Q2 2025) and $7.25 million (Q4 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,140.41 Bn 1,108.99 Bn 19.71 Bn 33.88 Bn
2 Johnson & Johnson 618.57 Bn 537.10 Bn 17.26 Bn 84.97 Bn
3 AbbVie 509.95 Bn 483.06 Bn 12.70 Bn -5.94 Bn
4 Merck 366.63 Bn 321.01 Bn 12.21 Bn 41.98 Bn
5 Novartis Ag 298.47 Bn 262.46 Bn 11.24 Bn 41.95 Bn
6 Astrazeneca 263.21 Bn 236.89 Bn 12.86 Bn 50.37 Bn
7 Amgen 236.71 Bn 192.11 Bn 7.24 Bn 11.69 Bn
8 Gilead Sciences 193.05 Bn 167.25 Bn 6.22 Bn 11.83 Bn
9 Pfizer 171.45 Bn 118.10 Bn 10.94 Bn 85.49 Bn
10 NewcelX 11.69 Mn 5.02 Mn - 6.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.04 Mn
Dec 31, 2025 7.25 Mn
Jun 30, 2025 -15.80 Mn
Dec 31, 2024 -8.00 Mn
Jun 30, 2024 -9.27 Mn
Dec 31, 2023 -1.20 Mn
Jun 30, 2023 -4.29 Mn
Dec 31, 2022 111,000.00
Jun 30, 2022 -4.04 Mn
Dec 31, 2021 542,388.00
Jun 30, 2021 4.25 Mn
Dec 31, 2020 -8.98 Mn
Dec 31, 2019 -6.17 Mn
API Access

NewcelX Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=NCEL&period=max&api_key=YOUR_API_KEY